Cargando…

Is tumour volume an independent predictor of outcome after radical prostatectomy for high-risk prostate cancer?

BACKGROUND: Preoperative PSA, ISUP grade group (GG), prostate examination and multiparametric MRI (mpMRI) form the basis of prostate cancer staging. Unlike other solid organ tumours, tumour volume (TV) is not routinely used aside from crude estimates such as maximum cancer core length. The aim of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Raison, Nicholas, Servian, Pol, Patel, Amit, Santhirasekaram, Ainkaran, Smith, Andrew, Yeung, Maidie, Lloyd, Josephine, Mannion, Ethna, Rockall, Andrea, Ahmed, Hashim, Winkler, Mathias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247356/
https://www.ncbi.nlm.nih.gov/pubmed/34845306
http://dx.doi.org/10.1038/s41391-021-00468-4
_version_ 1785055182893088768
author Raison, Nicholas
Servian, Pol
Patel, Amit
Santhirasekaram, Ainkaran
Smith, Andrew
Yeung, Maidie
Lloyd, Josephine
Mannion, Ethna
Rockall, Andrea
Ahmed, Hashim
Winkler, Mathias
author_facet Raison, Nicholas
Servian, Pol
Patel, Amit
Santhirasekaram, Ainkaran
Smith, Andrew
Yeung, Maidie
Lloyd, Josephine
Mannion, Ethna
Rockall, Andrea
Ahmed, Hashim
Winkler, Mathias
author_sort Raison, Nicholas
collection PubMed
description BACKGROUND: Preoperative PSA, ISUP grade group (GG), prostate examination and multiparametric MRI (mpMRI) form the basis of prostate cancer staging. Unlike other solid organ tumours, tumour volume (TV) is not routinely used aside from crude estimates such as maximum cancer core length. The aim of this study is to assess the role of TV as a marker for oncological outcomes in high-risk non-metastatic prostate cancer. METHODS: A prospectively maintained database of patients undergoing minimally invasive (laparoscopic or robot-assisted laparoscopic) radical prostatectomy at a UK centre between 2007 and 2019 were analysed. A total of 251 patients with NCCN high or very high-risk prostate cancer were identified. Primary outcome measure was time to biochemical recurrence (BCR) and the secondary outcome was time to treatment failure (TTF). TV was measured on the pathological specimen using the stacking method. Multivariable cox regression analysis was used to identify factors predicting BCR and TFF. TV as a predictor of BCR and TFF was further analysed through time-dependent receiver operating characteristic (ROC) curves. Kaplan–Meier survival estimates were used to evaluate TV cut-off scores. RESULTS: Median follow up was 4.50 years. Four factors were associated with BCR and TFF on multivariable analysis (TV, pathological GG, pathological T stage, positive margin >3 mm). Area under the Curve (AUC) for TV as a predictor of BCR and TTF at 5 years was 0.71 and 0.75, respectively. Including all 4 variables in the model increased AUC to 0.84 and 0.85 for BCR and TFF. A 2.50 cm TV cut off demonstrated a significance difference in time to BCR, p < 0.001. CONCLUSIONS: Pathological tumour volume is an independent predictor of oncological outcomes in high risk prostate cancer but does not add significant prognostic value when combined with established variables. However, the option of accurate TV measurement on mpMRI raises the possibility of using TV as useful marker for preoperative risk stratification.
format Online
Article
Text
id pubmed-10247356
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-102473562023-06-09 Is tumour volume an independent predictor of outcome after radical prostatectomy for high-risk prostate cancer? Raison, Nicholas Servian, Pol Patel, Amit Santhirasekaram, Ainkaran Smith, Andrew Yeung, Maidie Lloyd, Josephine Mannion, Ethna Rockall, Andrea Ahmed, Hashim Winkler, Mathias Prostate Cancer Prostatic Dis Article BACKGROUND: Preoperative PSA, ISUP grade group (GG), prostate examination and multiparametric MRI (mpMRI) form the basis of prostate cancer staging. Unlike other solid organ tumours, tumour volume (TV) is not routinely used aside from crude estimates such as maximum cancer core length. The aim of this study is to assess the role of TV as a marker for oncological outcomes in high-risk non-metastatic prostate cancer. METHODS: A prospectively maintained database of patients undergoing minimally invasive (laparoscopic or robot-assisted laparoscopic) radical prostatectomy at a UK centre between 2007 and 2019 were analysed. A total of 251 patients with NCCN high or very high-risk prostate cancer were identified. Primary outcome measure was time to biochemical recurrence (BCR) and the secondary outcome was time to treatment failure (TTF). TV was measured on the pathological specimen using the stacking method. Multivariable cox regression analysis was used to identify factors predicting BCR and TFF. TV as a predictor of BCR and TFF was further analysed through time-dependent receiver operating characteristic (ROC) curves. Kaplan–Meier survival estimates were used to evaluate TV cut-off scores. RESULTS: Median follow up was 4.50 years. Four factors were associated with BCR and TFF on multivariable analysis (TV, pathological GG, pathological T stage, positive margin >3 mm). Area under the Curve (AUC) for TV as a predictor of BCR and TTF at 5 years was 0.71 and 0.75, respectively. Including all 4 variables in the model increased AUC to 0.84 and 0.85 for BCR and TFF. A 2.50 cm TV cut off demonstrated a significance difference in time to BCR, p < 0.001. CONCLUSIONS: Pathological tumour volume is an independent predictor of oncological outcomes in high risk prostate cancer but does not add significant prognostic value when combined with established variables. However, the option of accurate TV measurement on mpMRI raises the possibility of using TV as useful marker for preoperative risk stratification. Nature Publishing Group UK 2021-11-29 2023 /pmc/articles/PMC10247356/ /pubmed/34845306 http://dx.doi.org/10.1038/s41391-021-00468-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Raison, Nicholas
Servian, Pol
Patel, Amit
Santhirasekaram, Ainkaran
Smith, Andrew
Yeung, Maidie
Lloyd, Josephine
Mannion, Ethna
Rockall, Andrea
Ahmed, Hashim
Winkler, Mathias
Is tumour volume an independent predictor of outcome after radical prostatectomy for high-risk prostate cancer?
title Is tumour volume an independent predictor of outcome after radical prostatectomy for high-risk prostate cancer?
title_full Is tumour volume an independent predictor of outcome after radical prostatectomy for high-risk prostate cancer?
title_fullStr Is tumour volume an independent predictor of outcome after radical prostatectomy for high-risk prostate cancer?
title_full_unstemmed Is tumour volume an independent predictor of outcome after radical prostatectomy for high-risk prostate cancer?
title_short Is tumour volume an independent predictor of outcome after radical prostatectomy for high-risk prostate cancer?
title_sort is tumour volume an independent predictor of outcome after radical prostatectomy for high-risk prostate cancer?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247356/
https://www.ncbi.nlm.nih.gov/pubmed/34845306
http://dx.doi.org/10.1038/s41391-021-00468-4
work_keys_str_mv AT raisonnicholas istumourvolumeanindependentpredictorofoutcomeafterradicalprostatectomyforhighriskprostatecancer
AT servianpol istumourvolumeanindependentpredictorofoutcomeafterradicalprostatectomyforhighriskprostatecancer
AT patelamit istumourvolumeanindependentpredictorofoutcomeafterradicalprostatectomyforhighriskprostatecancer
AT santhirasekaramainkaran istumourvolumeanindependentpredictorofoutcomeafterradicalprostatectomyforhighriskprostatecancer
AT smithandrew istumourvolumeanindependentpredictorofoutcomeafterradicalprostatectomyforhighriskprostatecancer
AT yeungmaidie istumourvolumeanindependentpredictorofoutcomeafterradicalprostatectomyforhighriskprostatecancer
AT lloydjosephine istumourvolumeanindependentpredictorofoutcomeafterradicalprostatectomyforhighriskprostatecancer
AT mannionethna istumourvolumeanindependentpredictorofoutcomeafterradicalprostatectomyforhighriskprostatecancer
AT rockallandrea istumourvolumeanindependentpredictorofoutcomeafterradicalprostatectomyforhighriskprostatecancer
AT ahmedhashim istumourvolumeanindependentpredictorofoutcomeafterradicalprostatectomyforhighriskprostatecancer
AT winklermathias istumourvolumeanindependentpredictorofoutcomeafterradicalprostatectomyforhighriskprostatecancer